Fate’s off-the-shelf CAR-T therapy shows early promise in treatment-resistant autoimmune disease

OHSU advances massive leap in medical science with cellular therapies

Resetting autoimmune disease with CAR cell therapies

Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus

This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells

OHSU logra un gran avance en la ciencia médica con las terapias celulares

Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors

This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an